Results 291 to 300 of about 14,877 (300)

Readministration of abciximab: Weighing the risks and benefits

Catheterization and Cardiovascular Interventions, 1999
openaire   +3 more sources

Benefits From Small Molecule Administration as Compared With Abciximab Among Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Angioplasty

Journal of the American College of Cardiology, 2009
Paolo Marino
exaly  

Prehospital Abciximab in ST-Segment Elevation Myocardial Infarction: Results of the Randomized, Double-Blind MISTRAL Study

Circulation. Cardiovascular Interventions, 2012
P. Ohlmann, Philippe Reydel, L. Jacquemin, F. Adnet, O. Wolf, J. Bartier, A. Weiss, F. Lapostolle, C. Gaultier, E. Salengro, H. Benamer, P. Guyon, B. Chevalier, S. Catan, P. Ecollan, T. Chouihed, M. Angioi, M. Zupan, F. Bronner, P. Bareiss, G. Steg, G. Montalescot, J. Monassier, O. Morel   +23 more
semanticscholar   +1 more source

Abciximab

Drugs, 2012
exaly   +2 more sources

Economic Impact of Same-Day Home Discharge After Uncomplicated Transradial Percutaneous Coronary Intervention and Bolus-Only Abciximab Regimen

JACC: Cardiovascular Interventions, 2010
Stéphane Rinfret Sm
exaly  

Abciximab (c7E3 Fab)

Drugs, 2012
exaly  

Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis

Journal of Thrombosis and Haemostasis, 2011
exaly  

Abciximab: benefits for some in ACS

Inpharma Weekly, 2006
openaire   +2 more sources

Routine use of abciximab in coronary stenting?

The Lancet, 1998
openaire   +3 more sources

A smooth ride for abciximab in the CADILLAC

Inpharma Weekly, 2000
openaire   +2 more sources